Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health
[1] Common adverse effects include nausea, vomiting, diarrhoea, and injection site reactions
How much weight can I lose with AOD-9604
To use, apply a few drops onto cleansed skin and gently pat until fully absorbed
Usage: 2400mg GHK-Cu in a 2oz jar
Throughout life, IGF-1 levels fluctuate, peaking during adolescence and dipping during childhood and old age